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Gossypol, a phenolic compound extracted from the
cotton plant, has been used as an oral male
contraceptive in China; few side effects other than
transient hypokalaemia have been reported (Qian &
Wang, 1984; Prasad & Diczfalusy, 1982). Recent
reports using experimental tumour models indicate
that gossypol may also be a potential anti-tumour
chemotherapeutic agent (Wang & Rao, 1984; Tso,
1984; Tuszynski & Cossu, 1984). The structure of
gossypol is shown in Figure 1; there is limited
rotation about the inter-naphthyl bond giving rise
to the chiral nature of the molecule. Gossypol,
when extracted from the cotton plant, is a mixture
of (+) and (-) enantiomers which have now been
separated (Matlin & Zhou, 1984). Since it has been
shown that the (-) enantiomer of gossypol is more
effective than the racemic mixture in producing
infertility in male hamsters (Matlin et al., 1985),
this led us to examine the cytotoxicity of the
enantiomers and the racemic mixture on normal
and tumour-derived cells in culture. The (-) form
of gossypol is more cytotoxic than the (+) form
and the degree of toxicity is influenced by plasma
proteins.
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Figure 1 Structure ofgossypol.
The effect of gossypol on cell proliferation was
studied using 24-well multiwell dishes (Nunc). Cells
(2 x 104) were added to each well and incubated for
24h before the addition of different concentrations
of gossypol which was dissolved in dimethyl-
sulphoxide immediately before use. After a further
3 day incubation cell growth was determined by
measuring cellular protein content. Cells were
washed with PBS and then fixed with
glutaraldehyde. After removing fixative cells were
stained with a solution containing 0.4 g kenacid
blue in 250ml ethanol and 630ml water to which
had been added 120ml of glacial acetic acid. Cells
were destained with water:ethanol:glacial acetic
acid (85:10:5). One millitre of a desorbing solution
(1 M potassium acetate in 70% ethanol) released the
stain from the cells and the resulting solutions were
measured spectrophotometrically at 570 nm.
Standards and controls were included and dose
response curves constructed by plotting increase in
protein content over the 3 day growth period
against gossypol concentration. The ID50 is the
concentration that brings about a 50% inhibition in
growth over this time. BCL-D1 cells are a human
diploid strain of fibroblasts (obtained from Gibco)
and skin fibroblasts were derived from explants of
human skin and used before fifth subculture. Cells
from hepatoma, pancreatic adenocarcinoma and
ovarian carcinoma were derived from ascites fluid.
They were grown in monolayer culture and
cytology and karyology used to ensure that they
were tumour-derived; cells from the three
carcinomas were used at third subculture. A B cell
line was donated by Dr M.J. Clemens and a T cell
line by Dr A.P. Johnstone. Both lymphoid cell lines
grew in suspension and to induce adherence to the
tissue culture surface in order to use the dye-
binding method of protein estimation, ug of
Concanavalin A was added to each well 30min
before fixation.
Table I shows the effect of racemic gossypol on a
number of cell types in terms of the concentration
that brought about a 50% reduction in cell
proliferation over a 3 day period. Gossypol
inhibited proliferation in tumour-derived cells as
well as normal fibroblasts.
BCL-D1 cells, a human diploid strain of
fibroblasts were sensitive to gossypol and further
studies were undertaken using these cells since in
contrast to most of the tumour-derived cells we
have used, they maintain consistent patterns of
growth over periods of many months.
The enantiomers of gossypol were prepared and
analyzed as described in Matlin & Zhou (1984).
Figure 2 shows dose response curves for the
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Table I Toxic effects ofgossypol on different cell types.
Cell type IDSO (,igml-1)
Hepatoma 4.6
Pancreatic adenocarcinoma 6.8
Ovarian carcinoma 3.9
BCL-Dl (embryonic lung diploid) 6.2
Human skin fibroblasts 5.3
B-cell lymphoma 7.4
T-cell lymphoma 6.9
ID50 values for racemic gossypol were determined as
described. The results represent the mean value of 3
experiments. Maximum variation between experiments
was 16%.
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Figure 2 Cytotoxicity of enantiomers of gossypol.
The effect of (+) gossypol (0 0), (-) gossypol
(0-0)orracemicgossypol([I-l)onthegrowthof
BCL-D1 cells. Cell proliferation was determined by the
dye-binding method as described. Results are
expressed as mean+s.d. oftriplicate wells.
separate enantiomers and the racemic mixture. The
(-) enantiomer of gossypol is more cytotoxic than
the (+) form. In 4 four similar experiments the
mean concentration of (-) gossypol necessary to
bring about a 50% reduction in cell growth was
1.9pgml-' compared to 12.7upgml-1 for the (+)
form. The mean value for the racemic mixture was
6.2jgml-1 and thus represents a value mid-way
between the two enantiomeric forms. In the case of
all the tumour-derived cells described in Table I,
the concentration of the (-) enantiomer required
to produce cytotoxicity was -I10% of that required
in the case of the (+) enantiomer.
While at lower concentrations gossypol inhibits
cellular proliferation, at higher concentrations the
compound brings about complete cell lysis. Figure
3 shows two dose response curves for (-) gossypol;
one is for the inhibition of proliferation and the
other is for cell lysis. When the (+) enantiomer was
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Figure 3 Cytotoxic effects of (-) gossypol on human
diploid fibroblasts. The effect of gossypol on cell
growth was determined as described while the cytolytic
effects of gossypol were determined by examination of
cultures with a phase-contrast microscope 24h after
the addition of gossypol. In the case of cell lysis, 100
cells were counted in each of triplicates cultures.
Results are expressed as mean+s.d. oftriplicate wells.
used the curves were shifted to the right as
expected. However, due to the lower cytoxicity of
(+) gossypol it was impossible with this enantiomer
to achieve 100% cell lysis because of the limited
solubility ofthe compound.
Even with high doses of (-) gossypol cell lysis
does not occur rapidly but takes -16h to become
visible and cells which have not lysed by 24h will
not do so without the addition of further gossypol.
There is thus a clear delineation between
concentrations that inhibit growth and
concentrations that cause cell lysis.
When gossypol was added to cultures and then
removed with thorough washing at time intervals it
was found that 30min exposure was adequate to
bring about the cytotolytic effect. Thus the
biochemical effects of gossypol occur rapidly after
addition even though cellular changes may not be
obvious for some hours.
Although gossypol is stable in dimethyl-
sulphoxide, once it has been added to tissue
culture medium there is a loss ofcytotoxic potential.
When gossypol was added to culture fluid
and incubated at 37°C before addition to cells, the
chemical lost 10% per hour of its cytotoxic
potential.
The likely explanation is a binding of gossypol to
plasma proteins that form the serum supplement to
the growth medium. An earlier report demonstrated
the effect of albumin on gossypol cytotoxicity
(Haspel et al., 1983). Figure 4 shows for (-) and
(+) enantiomers of gossypol the concentrations
needed to bring about a 50% reduction in growth
in the presence of different concentrations of
human serum. The figure shows that the ID50 inCYTOTOXICITY OF ENANTIOMERS OF GOSSYPOL 513
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Figure 4 The effect of serum concentration on
gossypol toxicity. BCL-Dl cells were plated in 10%
human serum and incubated for 24h at which time
medium was replaced with different concentrations of
(+) gossypol (0-0) (or (-) gossypol (@-O)
and different concentrations of serum. At the end of a
three day period ID50 values were determined.
Separate controls for each concentration of serum
were eseential since there is an effect of serum
concentration on growth rate. Results shown are the
mean+s.d. of 3 separate experiments.
the presence of 100% serum is two orders of
magnitude greater than that found in 1% serum.
The values shown in Figure 4 for 10% serum are
different from those of Figure 2 since in the latter
experiments foetal calf serum was used rather than
human serum. While human serum has a total
protein concentration of 70-75gl-i, foetal calf
serum is variable, depending on gestational age,
and can range from <30gl-P to >50gl-l. The
effect of serum concentration on cytotoxicity of
gossypol indicates that a reported value is only
valid in terms of the concentration and type of
serum used in the experiment.
More than 10,000 men have participated in
clinical trials relating to the anti-fertility effects of
gossypol and a low incidence of side effects has
been reported (Qian & Wang, 1984; Prasad &
Diczfalusy, 1982). The question arises as to why
gossypol does not have an effect on bone marrow
cell proliferation. The answer probably lies in the
protection afforded by higher protein
concentrations. Most cells are perfused not by
plasma but rather by a fluid that is an ultrafilitrate
of plasma formed at the blood capillaries. Thus the
interstitial fluid found in most tissues has a protein
concentration that is less than one quarter that of
plasma (Knox & Pflug, 1983).
There are exceptions such as the liver and bone
marrow. These tissues do not have a capillary-type
microcirculation and the interstitial fluid is
effectively plasma and this will protect cells from
the toxic effects of the gossypol. The (-)
enantiomer of gossypol will have considerable
benefits over the racemic mixture. The cytotoxic
dose of this form is lower and this may reduce the
incidence of side-effects. Gossypol has only limited
solubility in biological fluids and thus the use of the
purified (-) form will also ensure that cytotoxic
levels can be reached.
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